Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury

Scientific Reports

Volumn 4, Issue , 2014, Pages 7027-

  Yang, Penghui ^a,b   Gu, Hongjing ^a   Zhao, Zhongpeng ^a   Wang, Wei ^c   Cao, Bin ^d   Lai, Chengcai ^a   Yang, Xiaolan ^a   Zhang, LiangYan ^a   Duan, Yueqiang ^a   Zhang, Shaogeng ^b   Chen, Weiwen ^e   Zhen, Wenbo ^e   Cai, Maosheng ^f   Penninger, Josef M ^g   Jiang, Chengyu ^c   Wang, Xiliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING 302 HOSPITAL   (China)

^c TSINGHUA UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Quanzhou First Hospital   (China)

^f Department of Medicine   (China)

^g INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN CONVERTING ENZYME 2; ANTIVIRUS AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; IMIDAZOLE DERIVATIVE; LOSARTAN; PYRIDINE DERIVATIVE;

ACUTE LUNG INJURY; ANIMAL; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; INFLUENZA A VIRUS (H7N9); LUNG; METABOLISM; MORTALITY; MOUSE; ORTHOMYXOVIRIDAE INFECTIONS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SURVIVAL; VIROLOGY; VIRUS LOAD;

ACUTE LUNG INJURY; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; ANTIVIRAL AGENTS; GENE EXPRESSION; HUMANS; IMIDAZOLES; INFLUENZA A VIRUS, H7N9 SUBTYPE; LOSARTAN; LUNG; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PEPTIDYL-DIPEPTIDASE A; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 84922551964     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07027     Document Type: Article

References (25)

1. Wu, Y. & Gao, G. F. Lessons learnt from the human infections of avian-origin influenza A H7N9 virus: live free markets and human health. Sci. China. Life. Sci. 56, 493-4 (2013).
2. Li, J. et al. Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human. Sci. China. Life. Sci. 56, 485-92 (2013).
3. Gao, G. F. & Wu, Y. Haunted with and hunting for viruses. Sci. China. Life. Sci. 56, 675-7 (2013).
4. Belser, J. A. et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501, 556-9 (2013).
5. Gao, H. N. et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N. Engl. J. Med. 368, 2277-85 (2013).
6. Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368, 1888-97 (2013).
7. Liu, D. et al.Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 381, 1926-32 (2013).
8. Shu, Y. Human infection with H7N9 virus. N. Engl. J. Med. 369, 880 (2013).
9. Zhou, J. et al. Biological features of novel avian influenza A (H7N9) virus. Nature 499, 500-3 (2013).
10. Zhu, H. et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341, 183-6 (2013).
11. Crackower, M. A. et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417, 822-8 (2002).
12. Zhong, J. et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation 122, 717-28, 18 p following 728 (2010).
13. Oudit, G. Y. et al. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc. Res. 75, 29-39 (2007).
14. Burrell, L. M., Johnston, C. I., Tikellis, C.&Cooper, M. E. ACE2, a new regulator of the renin-angiotensin system. Trends. Endocrinol. Metab. 15, 166-9 (2004).
15. Kuba, K. et al . A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11, 875-9 (2005).
16. Hashimoto, T. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477-81 (2012).
17. Imai, Y. et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112-6 (2005).
18. Perlot, T. & Penninger, J. M. ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition. Microbes. Infect. 15, 866-73 (2013).
19. Song, B. et al. Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways. Regul. Pept. 185, 44-51 (2013).
20. Zou, Z. et al. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat. Commun. 5, 3594 (2014).
21. Huang, F. et al. Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat. Commun. 5, 3595 (2014).
22. Wang, W. et al. Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury. Cell. Res. 23, 577-80 (2013).
23. Donoghue, M. et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-9 (2000).
24. Lovren, F. et al. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am. J. Physiol. Heart. Circ. Physiol. 295,H1377-84 (2008).
25. Imai, Y. et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235-49 (2008).